What is the future for Scapholunate interosseous ligament reconstruction?
Archives of Clinical and Experimental Orthopaedics · 2018
DOI: 10.29328/journal.aceo.1001004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Clinical and Experimental Orthopaedics, 2018. Verfasst von Amelia Carr und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This opinion paper provides a summary of the current reconstructive surgical techniques for the scapholunate interosseous ligament (SLIL) and critically highlights their benefits and shortcomings. Due to limited success with direct repair of the ligament, current practice focuses on achieving biomechanical stabilization and does not allow for tissue regeneration to occur. In addition, the biomechanical behaviour of the ligament is still poorly described and understood, resulting in a very large variation in published mechanical parameters. Therefore, a thorough understanding of the biomechanics of the joint, via both experimental testing and numerical modelling is necessary for enabling the design of the next generation of implants in order to address mechanical stabilisation and regeneration.
Zitieren
APA
Carr, A., Ivanovski, S., Bindra, R., & Vaquette, C. (2018). What is the future for Scapholunate interosseous ligament reconstruction?. Archives of Clinical and Experimental Orthopaedics. https://doi.org/10.29328/journal.aceo.1001004
Vancouver
Carr A, Ivanovski S, Bindra R, Vaquette C. What is the future for Scapholunate interosseous ligament reconstruction?. Archives of Clinical and Experimental Orthopaedics. 2018. doi:10.29328/journal.aceo.1001004
BibTeX
@article{Carr2018,
author = {Carr, Amelia and Ivanovski, Saso and Bindra, Randy and Vaquette, Cedryck},
title = {What is the future for Scapholunate interosseous ligament reconstruction?},
journal = {Archives of Clinical and Experimental Orthopaedics},
year = {2018},
doi = {10.29328/journal.aceo.1001004}
}
EUVIMED